{"ticker": {"uuid": "5aad7a09-fe4a-41af-9f48-13cdece5f3e5", "symbol": "KLRA", "name": "Kailera Therapeutics, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Kailera Therapeutics, Inc. (NASDAQ:KLRA) Short Interest Up 96.0% in June", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNdVBzV0JIT0NLMGJ1MHIzODQxVko0dHJ5MFBJaFB0Sm5WMlVjc2xmaWNhU2VlNGMxR25BcGoyeHF0RzZ4N1NZekh6OTgwY1NYSnB3WGwtREVjMEVXYVlseDRncUh4RmRoeWh6ZmRyV3RkUU4zM241eVVwZG9ELVcxdXZJSDdyR3JRU1k5N1BsUTBkM1lOeTFNMC1yYXZqdHFzb2xYLTJ4RUFHNVd6SDRlZDNOMFhFTFhsSExR?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T22:45:53+00:00", "published_display": "16 Jul 2026 22:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Kailera Therapeutics (NASDAQ:KLRA) Hits New 52-Week Low - What's Next?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNUEZCQ24yNjl3MlYxZmNLQzkwdFRGR091cG1wT0lsQVFoeGs2Qzl2b0hSaGZNT1ZHYlI2cGpyeXFsX2RwLV9qcmN6MDlaLW1lRmlGNnJMVjhEcEJzeWpodHQ3OWZfSFgyTGNaOHJnVEU5bWNfVThOajBJWGJQX1JrdVpOellQb0hPWEJEMlFpeld3RzJIbzM0QzRNejhLQ2xXWFkwNXI3VmRHTExTSkZNTUgwZzVReDJB?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T18:12:41+00:00", "published_display": "16 Jul 2026 18:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Kailera Therapeutics (KLRA) is One of the Best IPO Stocks with Huge Upside Potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOd1NLTWFvUTVuNC1sWUgwcElqVVVSTk92Vzd4VmE3TkhzajNQUUZ0Q3dNYVlEem1RRUNYZHpuU0RPMWhnS1J2OVYxUkszREhYWEx5aHVLRHVuT1QweGpIbFlaWXFzbjFrU2MtQWJTRGhKRi1acE9hMXB6a1FwYmYwdXhhNGR6ZVg1bGp0YmVXcDNXQVBjUUxVZzY4WQ?oc=5", "source_name": "Market source", "published_at": "2026-07-10T07:00:00+00:00", "published_display": "10 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Stock: A Second-Wave Obesity Platform With More Than One Way To Win (NASDAQ:KLRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPVEpZenl6S1AtUDJBVFlpM09pRk0zRm8yTHM2a3JEN09EU0F5emNFSWxmSVVhdldLNElMRmRPYU50QS1zTjJnRl8zTEw0VzlxdjYtNVk1Y21tWE5hZGM1Y0IzLXk5YWFnRlpCanlfVjhlLXNOY1pjUG1TcS1ObUkzd2ZrY3ZONUJMMGNOV284a1VoRjRuS2ZMbkQ1Q1VrMloxRlM4UjB2dlp2SWd4VDFyQmZvWi1LWWV3NmlkcU1SZw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics (KLRA) officer receives 175,000 stock options at $23.30 strike", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPQ1FJUUYtOGtnejVnakdpczh0eEkzVzlCLW9yT2hmVlJPWlQ1RGtFOGY3NklyUjlmd3hTRjNXLWhSd1pJTGpaS2dpcXQ4eEFMNlFyZll4VDNVdHYxX0FGc3dGX1QxX1ctR2tqN25reUVHS193UjVLNDgzMk9ZQXlVQUwzb3cwV3FldHRpOTZHTVVLMmJNcW51M3dKZzVpZFVqSHluN3k5eVkyMnhEZE43SXN0LVlwcnVvMnc?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-08T20:20:36+00:00", "published_display": "08 Jul 2026 20:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera weight loss pill trial results: Nausea sinks stock", "summary": "", "url": "https://finance.yahoo.com/m/c98232a0-7f31-3d14-9ec9-40d5cde953c1/kailera-weight-loss-pill.html", "source_name": "Quartz", "published_at": "2026-07-08T14:10:57+00:00", "published_display": "08 Jul 2026 14:10", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Update: Kailera Says Oral Small Molecule KAI-7535 Achieves Up to 11% Weight Loss in Phase 3 Trial; Shares Fall", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/kailera-says-oral-small-molecule-184958173.html", "source_name": "MT Newswires", "published_at": "2026-07-07T18:49:58+00:00", "published_display": "07 Jul 2026 18:49", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Says Oral Small Molecule KAI-7535 Achieves Up to 11% Weight Loss in Phase 3 Trial", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/kailera-says-oral-small-molecule-120808915.html", "source_name": "MT Newswires", "published_at": "2026-07-07T12:08:08+00:00", "published_display": "07 Jul 2026 12:08", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera says obesity pill succeeds in late-stage trial in China", "summary": "", "url": "https://finance.yahoo.com/m/a57bd7e0-c606-368c-8aa6-31d3248c0205/kailera-says-obesity-pill.html", "source_name": "BioPharma Dive", "published_at": "2026-07-07T11:59:52+00:00", "published_display": "07 Jul 2026 11:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/kailera-therapeutics-announces-positive-topline-110000480.html", "source_name": "GlobeNewswire", "published_at": "2026-07-07T11:00:00+00:00", "published_display": "07 Jul 2026 11:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera shares tumble on high nausea rates despite weight-loss drug's success", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPQ3l3bk5oa09KNnVBQzRqNkRfNUhjNlFXeDlVTVJXalRYWWI4WnA3TDRFYVZJSXVnSU0xREh4cFc1a3NhUUlYcnRaQkNRaXhXd0UyYnY1SmhVUFk2NnBETzBKRjh5ajFIN3hRNXR6Sy1FZExURkZiMDZmQUpUSkxQR3FqNWhGUXR4czFaTkhvNmd6RDBjTl84Mzhob0tONGVYUm9uTWxMM1JoT013SEJ2NWF6TndIaVgtOTRMa2huSVEwZTQ?oc=5", "source_name": "Reuters", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera posts late-stage trial data for oral GLP-1 drug (KLRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQVWFDRDVaanVjSDFGazR3c2lmTzhJdC1JMW5uNHBVTVlPeVRkeWFXZ1FkdEJTT3h0VEtrTFB2ZGZvQlVoUWFKNEtoOERUMkZhLUl6V3VndFlrSnd2MnJUZzNCVnlRNUFWOUxCWm5qSmNiTGRpZk1ybVo1b3pQSk80Nlo4UTJJeThmTEhWUEh1RndpQkk?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera's oral GLP-1 pill posted 11.1% weight loss in Phase 3", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOYnNadEJpUzZGUFctYTh4MXRPeGZ0MzdWRl9CbHY0Rjc5WmtGTGxzTm1oRUxLaXF6OG9OTFVkWmxnaENBSEpNMW1GbkpwdVFHa3Q2Q3dWSEwyb2lEV24wUFMtUk9MR1A0REhMbTZMRzVVdk5JaHdUT20wVDZ1WURQeXU5NTVPcjZrVUs1LUVYTWoyVkVJbUN0eERjc2RYU1QyTFAxNXVsbDVlemwyWnFzS1Z5N3M5Zm8?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics (KLRA) Stock Looks Overvalued Despite Its 20% Slump", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQTkxKNGRzNXI2OGlfZVpKYUx6dlBDNXJWTjZuMlQ3RmFCZFlLZk9oc2dZSnNIZzNtR0FKWElTdDZVTTAtdC00aUpjVXRZN09fQnRTd0ZvY2l3ekVtUnlFT3doZUJpdUtRMXJ2eS1GcTlPWGVLejUtYVNRVk9OU05PdkVLZVlyb2lhXy00R2oyZThvSUFhaVRsZVloSVhHNzBrcHNqUg?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWkdoUDRJdkh3QndoZ3J2OHBvOEJlMUFEYjc1X3pLZGFXUlJ6eS1iNXhpYzNyd1NSZGxPOUdDM0xnZW9RcS1kdWNwR0xydVFVcEFGVmhfWWF5SFhYTmR5dXM0cTRIUENtbTc5bUpuNTNZQ0h0QWhMbnZDdGpfYjRWM2c3SWlCOHVJYTVoaUdDYnk2cTRKWWZTZHFvXzZDMTFmOGRUUUhyX3J6RUE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Kailera Therapeutics (KLRA) Insider Scooped up an Additional 500,000 Shares for $8.0 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQT0ZDcGlZZXNBQ19CMXVSdmF0cU01Sl9tdDJFc3F0a1c0U3diTzNNNkRIRjF2T1VKV21OeUxUck1zNG1YVEloR1N6Ry16M3p0eDc2M1RhZW9RUWFQYS1Lc1VCbWpOaF9EWUMxbm81NGxBYWxmNHNranByblF2MVg0ZERFRmVTbXB6WFNGa3VaMzVaUEtlSnBYWks4bE5sZjNpbV9TNVNGZVpQTVFVcm1obmp1TGZndzV5SWc2aS1ZUHFfMXBKYVJsZV9DMUFlVlVJY2VZQ1BXVmtmaE14?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters\u2019 Option to Purchase Additional Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNOGpzZEVfUDdHVjZDVkt3NEFJcHFqaFpUZzNuRVhXOXlQNGFoMDBZQmtSZno1cGZ0WF9Mbm1QTXRsLW1nenB2R1lQYmVrNTZodVI5dGFjcUVGaTdOMmZuN1BpbTRKVU45X200TDlIclpkMVdXblNrWjNGWmtHRGRtNjVPYkhGRG9sOU0yZEduNjZuWmJUTmNQWDNFaFdxRWNicXIwTWRXdUY?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KLRA: Kailera Therapeutics Inc. Latest Stock Price, Analysis, News and Trading Ideas", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSkFVX3lxTFBNR0tTNWJIVlNHTWg2QjUyMGtwX2ZKbDdMN2dUb29rNGw1NlI5T2NxNHkyRHZDUWVzZ2VRTXVLU2haVWRfRndiSHN3?oc=5", "source_name": "Stocktwits", "published_at": "2026-04-19T16:48:52+00:00", "published_display": "19 Apr 2026 16:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics (KLRA) Stock Price, News & Analysis $KLRA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE8xNHFTeEpFV3U2Y2laRlFocDVuQWRYSkhFSHlmS3dSSU5UOW1LODhob3F3U1dVckZqQXU3eXRLekdveWVDYTNHUTNvWnZ4Qm1fcjV6azl1eVJTUQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-04-18T23:39:40+00:00", "published_display": "18 Apr 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics, Inc (KLRA) Stock Price Today: $19.30", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFA3clBiMkowYVhpY3ZlWVJvNlR2MmsyZVNMVzBud1pmMFhxZUZYempEZFZsSDBaVnBJbXA2QWlXUVFRdFltYU55UldsMUdTSnRfOW1TQkVMSQ?oc=5", "source_name": "Gotrade", "published_at": "2026-04-18T00:22:02+00:00", "published_display": "18 Apr 2026 00:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats up", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPMEU0SDhrcWdfRktnb0puemNGVHdZOWRJbTcxdDNFWWZpaUpHcTdCTDhzbGRJSXlTSXJpUmNIR3dVZzdDazdDQkRIdVVqS2VRUjVoNnV1cDM4dk5mcTVjN0plRVlCRnRMLWVYRW9ibFFSd1dBZ3JNNjc2ZWZIUWhYX0luY2VOWGJQeWNBeDdWbzV4SDMxc1p3MGhReFU0WDQzQ25DMzNVX1JFWUgzQ3BneW9BZ2h0M2ZOMVhqVjVVNC00Z0dtZlRtWFhOZ2VySElCdEFZaQ?oc=5", "source_name": "Reuters", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Obesity Firm Kailera Therapeutics Up 63% After $625 Million IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOMm1na3g1LXl5d19mZXZzdlN1QlNYYXpZQmJLNlhZdWRBbFZRWGN0elBFc1RyMkpmd0dwLW9IeWsyRTU5bHREVTZWQWJSNjhWUUkzajdGZnJVRUtUOEFESWR2SVpiSEgwNnhQSkxqQzhkV0J3WFdCVVBvb1hTSlB3N3IyTEVtVEV0aHZJSUluZTZCU1ZjRy12dDZJaU5tUEtacVYxSTAtYlBoTlJZZWdjQUZn?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Obesity drug developer Kailera climbs on trading debut (KLRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPUUlqVHVUenVlMWZ0bm1ucXFxQXA4dGowOWlkWl9RZzhzS0tkblJsbkhOSHVwakh2YWtHUk90Q3BDLVpvaEc1RHF5am03U0V0Q2psWE9VYzhoOGtUSlVtN1E5Zng0MS1UX0lKMG5QMWYxbnVfbDJiMi1DWjduODNIS0l4clg1eGVGVWphd0pNLUV0cEk?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics (KLRA) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBsNjMwV0tnSG1rUkc0eVlWMzRjTWF6UnZFVTNvdmR2dDZqRVJJaUM3RGxyMEN3dXZ4ci0waEhsb0dOSnpQMmU3MlNxamhkcDZiM2pN?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-17T00:20:56+00:00", "published_display": "17 Apr 2026 00:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics Announces Pricing of Initial Public Offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOV3ZhaEhEblFVaEZzZmt3MDFKYXlSYVRJQlFiWElKXzJHcS1qdTdNM1djOW92NmhCcUJFNzhrcFdHcnhfeGVmSFhub3lIMFBGM2VpZUxGM0tON0FxLXczMkh5dy1hWWhHRnJOaFBiaF9aT21mSy02bEhEb0lwOGVjOWJQUUMtOUQ3Umg5NlhZNU9nSzZ6eGlLUWhhMk01WmlBUDVybWQzMnNra0UzenhJVQ?oc=5", "source_name": "Market source", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Obesity drug developer Kailera sets $625M IPO, trading starts Friday", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPeTRMTTVqbkpKOFhfQlRsS0FGcHhxdnFnTGhrQWt3eXJ5eXhUVDMtQWFFRlUtZmFxVDBDSDN5RGt5djg5WVJKRktMMTNvZnNRWU84QkQ2TFh0X2RaczJDeVB0dVlwNXVLeFVlS0ZKLWhJVmozSjlVZTc3SEs1OXFCWWY4c3UwdXJ3bFlNdlROMy1WUUxGZHNTNkJST0xzems4cjR3clhkWV9LSmJSMUtCRA?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics, Inc. Announces Pricing of Initial Public Offering at $16.00 Per Share", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQcTY0d3RCZUd4Y3daSm1UMDNRM2luTkFLU2tlWk1FTWVzMzNkWElYeloxSF9LWkM5WnRTTUFaUjNXaEZkalBUMjVMVlhTTTkxUDJ4b2RZWDdKa2cxREFUWnV3N2dCaU56c3d4VEpOYlhjdUw5cFVpdFlza1pKX0JMSU0wdWttQmJHT3FLd29Uemlnc2dwTjFfVnI5UlktUlVxV0NDd3RDaG9pbVVRNVdGSjhnU3JEWDkwa2l3YjlEQWtJblBMdVJN?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE1pR08xOW1ZYVJwSEktQTZQRTkwMmJaS2Zqc3pMOWs1dFNOZG5KZUxwd3pQcmxycmtvSEZmSm5rNzZVWjlxd3E4UVVnT1hQX1Br?oc=5", "source_name": "CNN", "published_at": "2026-04-14T16:38:17+00:00", "published_display": "14 Apr 2026 16:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Kailera Therapeutics, Inc. (NASDAQ:KLRA) Short Interest Up 96.0% in June", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNdVBzV0JIT0NLMGJ1MHIzODQxVko0dHJ5MFBJaFB0Sm5WMlVjc2xmaWNhU2VlNGMxR25BcGoyeHF0RzZ4N1NZekh6OTgwY1NYSnB3WGwtREVjMEVXYVlseDRncUh4RmRoeWh6ZmRyV3RkUU4zM241eVVwZG9ELVcxdXZJSDdyR3JRU1k5N1BsUTBkM1lOeTFNMC1yYXZqdHFzb2xYLTJ4RUFHNVd6SDRlZDNOMFhFTFhsSExR?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T22:45:53+00:00", "published_display": "16 Jul 2026 22:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics (NASDAQ:KLRA) Hits New 52-Week Low - What's Next?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNUEZCQ24yNjl3MlYxZmNLQzkwdFRGR091cG1wT0lsQVFoeGs2Qzl2b0hSaGZNT1ZHYlI2cGpyeXFsX2RwLV9qcmN6MDlaLW1lRmlGNnJMVjhEcEJzeWpodHQ3OWZfSFgyTGNaOHJnVEU5bWNfVThOajBJWGJQX1JrdVpOellQb0hPWEJEMlFpeld3RzJIbzM0QzRNejhLQ2xXWFkwNXI3VmRHTExTSkZNTUgwZzVReDJB?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T18:12:41+00:00", "published_display": "16 Jul 2026 18:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics (KLRA) is One of the Best IPO Stocks with Huge Upside Potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOd1NLTWFvUTVuNC1sWUgwcElqVVVSTk92Vzd4VmE3TkhzajNQUUZ0Q3dNYVlEem1RRUNYZHpuU0RPMWhnS1J2OVYxUkszREhYWEx5aHVLRHVuT1QweGpIbFlaWXFzbjFrU2MtQWJTRGhKRi1acE9hMXB6a1FwYmYwdXhhNGR6ZVg1bGp0YmVXcDNXQVBjUUxVZzY4WQ?oc=5", "source_name": "Market source", "published_at": "2026-07-10T07:00:00+00:00", "published_display": "10 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Stock: A Second-Wave Obesity Platform With More Than One Way To Win (NASDAQ:KLRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPVEpZenl6S1AtUDJBVFlpM09pRk0zRm8yTHM2a3JEN09EU0F5emNFSWxmSVVhdldLNElMRmRPYU50QS1zTjJnRl8zTEw0VzlxdjYtNVk1Y21tWE5hZGM1Y0IzLXk5YWFnRlpCanlfVjhlLXNOY1pjUG1TcS1ObUkzd2ZrY3ZONUJMMGNOV284a1VoRjRuS2ZMbkQ1Q1VrMloxRlM4UjB2dlp2SWd4VDFyQmZvWi1LWWV3NmlkcU1SZw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics (KLRA) officer receives 175,000 stock options at $23.30 strike", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPQ1FJUUYtOGtnejVnakdpczh0eEkzVzlCLW9yT2hmVlJPWlQ1RGtFOGY3NklyUjlmd3hTRjNXLWhSd1pJTGpaS2dpcXQ4eEFMNlFyZll4VDNVdHYxX0FGc3dGX1QxX1ctR2tqN25reUVHS193UjVLNDgzMk9ZQXlVQUwzb3cwV3FldHRpOTZHTVVLMmJNcW51M3dKZzVpZFVqSHluN3k5eVkyMnhEZE43SXN0LVlwcnVvMnc?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-08T20:20:36+00:00", "published_display": "08 Jul 2026 20:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera weight loss pill trial results: Nausea sinks stock", "summary": "", "url": "https://finance.yahoo.com/m/c98232a0-7f31-3d14-9ec9-40d5cde953c1/kailera-weight-loss-pill.html", "source_name": "Quartz", "published_at": "2026-07-08T14:10:57+00:00", "published_display": "08 Jul 2026 14:10", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Update: Kailera Says Oral Small Molecule KAI-7535 Achieves Up to 11% Weight Loss in Phase 3 Trial; Shares Fall", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/kailera-says-oral-small-molecule-184958173.html", "source_name": "MT Newswires", "published_at": "2026-07-07T18:49:58+00:00", "published_display": "07 Jul 2026 18:49", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Says Oral Small Molecule KAI-7535 Achieves Up to 11% Weight Loss in Phase 3 Trial", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/kailera-says-oral-small-molecule-120808915.html", "source_name": "MT Newswires", "published_at": "2026-07-07T12:08:08+00:00", "published_display": "07 Jul 2026 12:08", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera says obesity pill succeeds in late-stage trial in China", "summary": "", "url": "https://finance.yahoo.com/m/a57bd7e0-c606-368c-8aa6-31d3248c0205/kailera-says-obesity-pill.html", "source_name": "BioPharma Dive", "published_at": "2026-07-07T11:59:52+00:00", "published_display": "07 Jul 2026 11:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/kailera-therapeutics-announces-positive-topline-110000480.html", "source_name": "GlobeNewswire", "published_at": "2026-07-07T11:00:00+00:00", "published_display": "07 Jul 2026 11:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera shares tumble on high nausea rates despite weight-loss drug's success", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPQ3l3bk5oa09KNnVBQzRqNkRfNUhjNlFXeDlVTVJXalRYWWI4WnA3TDRFYVZJSXVnSU0xREh4cFc1a3NhUUlYcnRaQkNRaXhXd0UyYnY1SmhVUFk2NnBETzBKRjh5ajFIN3hRNXR6Sy1FZExURkZiMDZmQUpUSkxQR3FqNWhGUXR4czFaTkhvNmd6RDBjTl84Mzhob0tONGVYUm9uTWxMM1JoT013SEJ2NWF6TndIaVgtOTRMa2huSVEwZTQ?oc=5", "source_name": "Reuters", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera posts late-stage trial data for oral GLP-1 drug (KLRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQVWFDRDVaanVjSDFGazR3c2lmTzhJdC1JMW5uNHBVTVlPeVRkeWFXZ1FkdEJTT3h0VEtrTFB2ZGZvQlVoUWFKNEtoOERUMkZhLUl6V3VndFlrSnd2MnJUZzNCVnlRNUFWOUxCWm5qSmNiTGRpZk1ybVo1b3pQSk80Nlo4UTJJeThmTEhWUEh1RndpQkk?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera's oral GLP-1 pill posted 11.1% weight loss in Phase 3", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOYnNadEJpUzZGUFctYTh4MXRPeGZ0MzdWRl9CbHY0Rjc5WmtGTGxzTm1oRUxLaXF6OG9OTFVkWmxnaENBSEpNMW1GbkpwdVFHa3Q2Q3dWSEwyb2lEV24wUFMtUk9MR1A0REhMbTZMRzVVdk5JaHdUT20wVDZ1WURQeXU5NTVPcjZrVUs1LUVYTWoyVkVJbUN0eERjc2RYU1QyTFAxNXVsbDVlemwyWnFzS1Z5N3M5Zm8?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics (KLRA) Stock Looks Overvalued Despite Its 20% Slump", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQTkxKNGRzNXI2OGlfZVpKYUx6dlBDNXJWTjZuMlQ3RmFCZFlLZk9oc2dZSnNIZzNtR0FKWElTdDZVTTAtdC00aUpjVXRZN09fQnRTd0ZvY2l3ekVtUnlFT3doZUJpdUtRMXJ2eS1GcTlPWGVLejUtYVNRVk9OU05PdkVLZVlyb2lhXy00R2oyZThvSUFhaVRsZVloSVhHNzBrcHNqUg?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWkdoUDRJdkh3QndoZ3J2OHBvOEJlMUFEYjc1X3pLZGFXUlJ6eS1iNXhpYzNyd1NSZGxPOUdDM0xnZW9RcS1kdWNwR0xydVFVcEFGVmhfWWF5SFhYTmR5dXM0cTRIUENtbTc5bUpuNTNZQ0h0QWhMbnZDdGpfYjRWM2c3SWlCOHVJYTVoaUdDYnk2cTRKWWZTZHFvXzZDMTFmOGRUUUhyX3J6RUE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Kailera Therapeutics (KLRA) Insider Scooped up an Additional 500,000 Shares for $8.0 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQT0ZDcGlZZXNBQ19CMXVSdmF0cU01Sl9tdDJFc3F0a1c0U3diTzNNNkRIRjF2T1VKV21OeUxUck1zNG1YVEloR1N6Ry16M3p0eDc2M1RhZW9RUWFQYS1Lc1VCbWpOaF9EWUMxbm81NGxBYWxmNHNranByblF2MVg0ZERFRmVTbXB6WFNGa3VaMzVaUEtlSnBYWks4bE5sZjNpbV9TNVNGZVpQTVFVcm1obmp1TGZndzV5SWc2aS1ZUHFfMXBKYVJsZV9DMUFlVlVJY2VZQ1BXVmtmaE14?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters\u2019 Option to Purchase Additional Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNOGpzZEVfUDdHVjZDVkt3NEFJcHFqaFpUZzNuRVhXOXlQNGFoMDBZQmtSZno1cGZ0WF9Mbm1QTXRsLW1nenB2R1lQYmVrNTZodVI5dGFjcUVGaTdOMmZuN1BpbTRKVU45X200TDlIclpkMVdXblNrWjNGWmtHRGRtNjVPYkhGRG9sOU0yZEduNjZuWmJUTmNQWDNFaFdxRWNicXIwTWRXdUY?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KLRA: Kailera Therapeutics Inc. Latest Stock Price, Analysis, News and Trading Ideas", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSkFVX3lxTFBNR0tTNWJIVlNHTWg2QjUyMGtwX2ZKbDdMN2dUb29rNGw1NlI5T2NxNHkyRHZDUWVzZ2VRTXVLU2haVWRfRndiSHN3?oc=5", "source_name": "Stocktwits", "published_at": "2026-04-19T16:48:52+00:00", "published_display": "19 Apr 2026 16:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics (KLRA) Stock Price, News & Analysis $KLRA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE8xNHFTeEpFV3U2Y2laRlFocDVuQWRYSkhFSHlmS3dSSU5UOW1LODhob3F3U1dVckZqQXU3eXRLekdveWVDYTNHUTNvWnZ4Qm1fcjV6azl1eVJTUQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-04-18T23:39:40+00:00", "published_display": "18 Apr 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics, Inc (KLRA) Stock Price Today: $19.30", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFA3clBiMkowYVhpY3ZlWVJvNlR2MmsyZVNMVzBud1pmMFhxZUZYempEZFZsSDBaVnBJbXA2QWlXUVFRdFltYU55UldsMUdTSnRfOW1TQkVMSQ?oc=5", "source_name": "Gotrade", "published_at": "2026-04-18T00:22:02+00:00", "published_display": "18 Apr 2026 00:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats up", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPMEU0SDhrcWdfRktnb0puemNGVHdZOWRJbTcxdDNFWWZpaUpHcTdCTDhzbGRJSXlTSXJpUmNIR3dVZzdDazdDQkRIdVVqS2VRUjVoNnV1cDM4dk5mcTVjN0plRVlCRnRMLWVYRW9ibFFSd1dBZ3JNNjc2ZWZIUWhYX0luY2VOWGJQeWNBeDdWbzV4SDMxc1p3MGhReFU0WDQzQ25DMzNVX1JFWUgzQ3BneW9BZ2h0M2ZOMVhqVjVVNC00Z0dtZlRtWFhOZ2VySElCdEFZaQ?oc=5", "source_name": "Reuters", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Obesity Firm Kailera Therapeutics Up 63% After $625 Million IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOMm1na3g1LXl5d19mZXZzdlN1QlNYYXpZQmJLNlhZdWRBbFZRWGN0elBFc1RyMkpmd0dwLW9IeWsyRTU5bHREVTZWQWJSNjhWUUkzajdGZnJVRUtUOEFESWR2SVpiSEgwNnhQSkxqQzhkV0J3WFdCVVBvb1hTSlB3N3IyTEVtVEV0aHZJSUluZTZCU1ZjRy12dDZJaU5tUEtacVYxSTAtYlBoTlJZZWdjQUZn?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Obesity drug developer Kailera climbs on trading debut (KLRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPUUlqVHVUenVlMWZ0bm1ucXFxQXA4dGowOWlkWl9RZzhzS0tkblJsbkhOSHVwakh2YWtHUk90Q3BDLVpvaEc1RHF5am03U0V0Q2psWE9VYzhoOGtUSlVtN1E5Zng0MS1UX0lKMG5QMWYxbnVfbDJiMi1DWjduODNIS0l4clg1eGVGVWphd0pNLUV0cEk?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics (KLRA) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBsNjMwV0tnSG1rUkc0eVlWMzRjTWF6UnZFVTNvdmR2dDZqRVJJaUM3RGxyMEN3dXZ4ci0waEhsb0dOSnpQMmU3MlNxamhkcDZiM2pN?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-17T00:20:56+00:00", "published_display": "17 Apr 2026 00:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics Announces Pricing of Initial Public Offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOV3ZhaEhEblFVaEZzZmt3MDFKYXlSYVRJQlFiWElKXzJHcS1qdTdNM1djOW92NmhCcUJFNzhrcFdHcnhfeGVmSFhub3lIMFBGM2VpZUxGM0tON0FxLXczMkh5dy1hWWhHRnJOaFBiaF9aT21mSy02bEhEb0lwOGVjOWJQUUMtOUQ3Umg5NlhZNU9nSzZ6eGlLUWhhMk01WmlBUDVybWQzMnNra0UzenhJVQ?oc=5", "source_name": "Market source", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Obesity drug developer Kailera sets $625M IPO, trading starts Friday", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPeTRMTTVqbkpKOFhfQlRsS0FGcHhxdnFnTGhrQWt3eXJ5eXhUVDMtQWFFRlUtZmFxVDBDSDN5RGt5djg5WVJKRktMMTNvZnNRWU84QkQ2TFh0X2RaczJDeVB0dVlwNXVLeFVlS0ZKLWhJVmozSjlVZTc3SEs1OXFCWWY4c3UwdXJ3bFlNdlROMy1WUUxGZHNTNkJST0xzems4cjR3clhkWV9LSmJSMUtCRA?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kailera Therapeutics, Inc. Announces Pricing of Initial Public Offering at $16.00 Per Share", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQcTY0d3RCZUd4Y3daSm1UMDNRM2luTkFLU2tlWk1FTWVzMzNkWElYeloxSF9LWkM5WnRTTUFaUjNXaEZkalBUMjVMVlhTTTkxUDJ4b2RZWDdKa2cxREFUWnV3N2dCaU56c3d4VEpOYlhjdUw5cFVpdFlza1pKX0JMSU0wdWttQmJHT3FLd29Uemlnc2dwTjFfVnI5UlktUlVxV0NDd3RDaG9pbVVRNVdGSjhnU3JEWDkwa2l3YjlEQWtJblBMdVJN?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE1pR08xOW1ZYVJwSEktQTZQRTkwMmJaS2Zqc3pMOWs1dFNOZG5KZUxwd3pQcmxycmtvSEZmSm5rNzZVWjlxd3E4UVVnT1hQX1Br?oc=5", "source_name": "CNN", "published_at": "2026-04-14T16:38:17+00:00", "published_display": "14 Apr 2026 16:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 71, "total_relevant": 47, "sentiment_summary": {"positive": 7, "negative": 7, "neutral": 33, "score": 50, "total": 47, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 84, "events": [{"event": "general", "label": "Market update", "weight": 19.15, "count": 31}, {"event": "earnings", "label": "Earnings", "weight": 6.95, "count": 14}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.9, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 7, "negative_events": 7}, "market_context": {"has_market_context": true, "latest_close": 18.55, "latest_week": "2026-07-17", "one_week_move": -10.3, "four_week_move": -6.8, "twelve_week_move": -17.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -13.6, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 53.271, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-10.3% over one week, -6.8% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 59, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 13}, {"label": "Stock Titan", "count": 4}, {"label": "MarketBeat", "count": 3}, {"label": "Seeking Alpha", "count": 3}, {"label": "MT Newswires", "count": 2}, {"label": "Reuters", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "simplywall.st", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 39}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 31}, {"label": "Earnings", "count": 14}, {"label": "Macro sensitivity", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "84/100 classification confidence."}, {"label": "Company focus", "value": "39", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "8", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-10.3% over one week, -6.8% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Kailera Therapeutics, Inc. (NASDAQ:KLRA) Short Interest Up 96.0% in June"}], "updated_at": "2026-07-23T06:51:06.036031+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}